Literature DB >> 24335301

Encephalomyocarditis virus leader is phosphorylated by CK2 and syk as a requirement for subsequent phosphorylation of cellular nucleoporins.

Holly A Basta1, Valjean R Bacot-Davis, Jessica J Ciomperlik, Ann C Palmenberg.   

Abstract

Encephalomyocarditis virus and Theilovirus are species in the Cardiovirus genus of the Picornaviridae family. For all cardioviruses, the viral polyprotein is initiated with a short Leader (L) protein unique to this genus. The nuclear magnetic resonance (NMR) structure of LE from encephalomyocarditis virus (EMCV) has been determined. The protein has an NH2-proximal CHCC zinc finger, a central linker, and a contiguous, highly acidic motif. The theiloviruses encode the same domains, with one or two additional, COOH-proximal domains, characteristic of the human Saffold viruses (SafV) and Theiler's murine encephalomyelitis viruses (TMEV), respectively. The expression of a cardiovirus L, in recombinant form, or during infection/transfection, triggers an extensive, cell-dependent, antihost phosphorylation cascade, targeting nucleoporins (Nups) that form the hydrophobic core of nuclear pore complexes (NPC). The consequent inhibition of active nucleocytoplasmic trafficking is potent and prevents the host from mounting an effective antiviral response. For this inhibition, the L proteins themselves must be phosphorylated. In cells (extracts or recombinant form), LE was shown to be phosphorylated at Thr47 and Tyr41. The first reaction (Thr47), catalyzed by casein kinase 2 (CK2), is an obligatory precedent to the second event (Tyr41), catalyzed by spleen tyrosine kinase (Syk). Site mutations in LE, or kinase-specific inhibitors, prevented LE phosphorylation and subsequent Nup phosphorylation. Parallel experiments with LS (SafV-2) and LT (TMEV BeAn) proteins confirmed the general cardiovirus requirement for L phosphorylation, but CK2 was not the culpable kinase. It is likely that LS and LT are both activated by alternative kinases in different cell types, probably reactive within the Theilo-specific domains. IMPORTANCE An understanding of the diverse methods used by viruses to interfere with cellular processes is important because they can teach us how to control virus infections. This report shows how viruses in the same genus use different cellular enzymes to phosphorylate their proteins. If these processes are interfered with, the viruses are severely disabled.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335301      PMCID: PMC3911527          DOI: 10.1128/JVI.03150-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B.

Authors:  Jan Zoll; Willem J G Melchers; Jochem M D Galama; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

4.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.

Authors:  J Yoon; T Onodera; A L Notkins
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

6.  Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation.

Authors:  C M Dvorak; D J Hall; M Hill; M Riddle; A Pranter; J Dillman; M Deibel; A C Palmenberg
Journal:  Virology       Date:  2001-11-25       Impact factor: 3.616

7.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

8.  Encephalomyocarditis virus Leader protein hinge domain is responsible for interactions with Ran GTPase.

Authors:  Valjean R Bacot-Davis; Ann C Palmenberg
Journal:  Virology       Date:  2013-05-25       Impact factor: 3.616

Review 9.  Methods for measuring RGS protein phosphorylation by G protein-regulated kinases.

Authors:  Susanne Hollinger; John R Hepler
Journal:  Methods Mol Biol       Date:  2004

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more
  12 in total

1.  Solution structures of Mengovirus Leader protein, its phosphorylated derivatives, and in complex with nuclear transport regulatory protein, RanGTPase.

Authors:  Valjean R Bacot-Davis; Jessica J Ciomperlik; Holly A Basta; Claudia C Cornilescu; Ann C Palmenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

2.  Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.

Authors:  Kelly Watters; Bahar Inankur; Jaye C Gardiner; Jay Warrick; Nathan M Sherer; John Yin; Ann C Palmenberg
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  AMP-activated protein kinase phosphorylates EMCV, TMEV and SafV leader proteins at different sites.

Authors:  Holly A Basta; Ann C Palmenberg
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

4.  Binding interactions between the encephalomyocarditis virus leader and protein 2A.

Authors:  Ryan V Petty; Holly A Basta; Valjean R Bacot-Davis; Bradley A Brown; Ann C Palmenberg
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

5.  Cardiovirus Leader proteins bind exportins: Implications for virus replication and nucleocytoplasmic trafficking inhibition.

Authors:  Jessica J Ciomperlik; Holly A Basta; Ann C Palmenberg
Journal:  Virology       Date:  2015-10-19       Impact factor: 3.616

Review 6.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

Review 7.  Nuclear proteins hijacked by mammalian cytoplasmic plus strand RNA viruses.

Authors:  Richard E Lloyd
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

8.  Intracellular localization of Saffold virus Leader (L) protein differs in Vero and HEp-2 cells.

Authors:  Yishi Xu; Carla Bianca Luena Victorio; Qimei Ng; Mookkan Prabakaran; Yee-Joo Tan; Kaw Bing Chua
Journal:  Emerg Microbes Infect       Date:  2016-10-12       Impact factor: 7.163

Review 9.  Innate Immune Detection of Cardioviruses and Viral Disruption of Interferon Signaling.

Authors:  Eric C Freundt; Melissa Drappier; Thomas Michiels
Journal:  Front Microbiol       Date:  2018-10-12       Impact factor: 5.640

Review 10.  Induction and suppression of innate antiviral responses by picornaviruses.

Authors:  Qian Feng; Martijn A Langereis; Frank J M van Kuppeveld
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-18       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.